MS4A1 and neoplasm: To validate the prognostic value of TLS in HGSOC, we performed immunohistochemistry of CD20 (B cell surface marker) on 242 HGSOC tumor sections from Hammersmith Hospital, London (HH cohort; Figures 1D and S1C and Table 1).